WordPress database error: [Table 'ffpharma.wp_WP_SEO_Cache' doesn't exist]
select * from wp_WP_SEO_Cache where ID='4779';


Warning: mysqli_num_fields() expects parameter 1 to be mysqli_result, bool given in /data/FujifilmPharma/wp-includes/class-wpdb.php on line 3574

WordPress database error: [Table 'ffpharma.wp_WP_SEO_Redirection' doesn't exist]
select * from wp_WP_SEO_Redirection where enabled=1 and regex='' and ( redirect_from = '/literature/asco-2022-a-phase-1-first-in-human-dose-escalation-and-biomarker-trial-of-liposomal-gemcitabine-ff-10832-in-patients-with-advanced-solid-tumors-journal-of-clinical-oncology-ascopubs-org' OR redirect_from = '/literature/asco-2022-a-phase-1-first-in-human-dose-escalation-and-biomarker-trial-of-liposomal-gemcitabine-ff-10832-in-patients-with-advanced-solid-tumors-journal-of-clinical-oncology-ascopubs-org/')


Warning: mysqli_num_fields() expects parameter 1 to be mysqli_result, bool given in /data/FujifilmPharma/wp-includes/class-wpdb.php on line 3574

WordPress database error: [Table 'ffpharma.wp_WP_SEO_Redirection' doesn't exist]
select * from wp_WP_SEO_Redirection where enabled=1 and regex<>'' and ('/literature/asco-2022-a-phase-1-first-in-human-dose-escalation-and-biomarker-trial-of-liposomal-gemcitabine-ff-10832-in-patients-with-advanced-solid-tumors-journal-of-clinical-oncology-ascopubs-org' regexp regex or '/literature/asco-2022-a-phase-1-first-in-human-dose-escalation-and-biomarker-trial-of-liposomal-gemcitabine-ff-10832-in-patients-with-advanced-solid-tumors-journal-of-clinical-oncology-ascopubs-org/' regexp regex ) order by LENGTH(regex) desc


Warning: mysqli_num_fields() expects parameter 1 to be mysqli_result, bool given in /data/FujifilmPharma/wp-includes/class-wpdb.php on line 3574

WordPress database error: [Table 'ffpharma.wp_WP_SEO_Cache' doesn't exist]
insert IGNORE into wp_WP_SEO_Cache(ID,is_redirected,redirect_from,redirect_to,redirect_type) values(4779,0,'','',0);

ASCO 2022: A phase 1, first-in-human, dose-escalation and biomarker trial of liposomal gemcitabine (FF-10832) in patients with advanced solid tumors. | Journal of Clinical Oncology (ascopubs.org) - FUJIFILM Pharmaceuticals USA

ASCO 2022: A phase 1, first-in-human, dose-escalation and biomarker trial of liposomal gemcitabine (FF-10832) in patients with advanced solid tumors. | Journal of Clinical Oncology (ascopubs.org)